##ANALYSISTYPE=SOMATIC_PAIR
##DESCRIPTION=tumor_af=Mutant allele frequency in tumor (Sample I17R018Ra01_01).
##DESCRIPTION=tumor_dp=Tumor Depth (Sample I17R018Ra01_01).
##DESCRIPTION=normal_af=Mutant allele frequency in normal (Sample I17R018Rb01_01).
##DESCRIPTION=normal_dp=Normal depth (Sample I17R018Rb01_01).
##DESCRIPTION=filter=Filter criteria from vcf file.
##DESCRIPTION=snp_q=Quality parameters - SNP quality (QUAL).
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, NM number, type, impact, exon number, HGVS.c, HGVS.p).
##DESCRIPTION=interpro=Interpro domains.
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in all populations of 1000g project.
##DESCRIPTION=ExAC=Allele frequency in all populations of ExAC project.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD database.
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=MetaLR=MetaLR effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=Sift=Sift effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen2=Polyphen2 (HVAR) effect prediction: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=FATHMM=FATHMM effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 15-20.
##DESCRIPTION=ihdb_hom=Homozygous variant counts in NGSD for the same processing system.
##DESCRIPTION=ihdb_het=Heterozyous variant counts in NGSD for the same processing system.
##DESCRIPTION=ihdb_wt=Wildtype variant counts in NGSD for the same processing system.
##DESCRIPTION=ihdb_allsys_hom=Homozygous variant counts in NGSD independent of the processing system.
##DESCRIPTION=ihdb_allsys_het=Heterozygous variant counts in NGSD independent of the processing system.
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validated=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Comments from the NGSD. Comments of other samples are listed in brackets!
##DESCRIPTION=gene_info=General gene information from the NGSD.
##DESCRIPTION=som_ihdb_c=Somatic variant count within NGSD.
##DESCRIPTION=som_ihdb_p=Projects with somatic variant in NGSD.
##DESCRIPTION=dna_tum_freq=Variant frequency.
##DESCRIPTION=dna_tum_depth=Sequencing depth at the variant position.
##DESCRIPTION=dna_ref_freq=Variant frequency.
##DESCRIPTION=dna_ref_depth=Sequencing depth at the variant position.
##FILTER=s.special_chromosome=Special chromosome.
#chr	start	end	ref	obs	tumor_af	tumor_dp	normal_af	normal_dp	filter	snp_q	gene	variant_type	coding_and_splicing	interpro	Pathway_KEGG_full	Function_description	Pathway_BioCarta_full	RepeatMasker	dbSNP	1000g	ExAC	gnomAD	COSMIC	OMIM	ClinVar	HGMD	phyloP	MetaLR	Sift	PolyPhen2	FATHMM	CADD	ihdb_hom	ihdb_het	ihdb_wt	ihdb_allsys_hom	ihdb_allsys_het	classification	classification_comment	validated	comment	gene_info	som_ihdb_c	som_ihdb_p	dna_tum_freq	dna_tum_depth	dna_ref_freq	dna_ref_depth
chr22	16154554	16154554	T	A	0.2188	32	0.0000	18		57	AP000525.9,LL22NC03-N14H11.1	intron_variant,non_coding_transcript_exon_variant	AP000525.9:ENST00000447898:intron_variant:MODIFIER:exon3/3:n.294-2733A>T:,AP000525.9:ENST00000437781:intron_variant:MODIFIER:exon7/7:n.832-2733A>T:,AP000525.9:ENST00000413768:intron_variant:MODIFIER:exon7/7:n.810-2733A>T:,LL22NC03-N14H11.1:ENST00000608286:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.213A>T:						rs879772142	0.0000	0.0000	0.0000																					0		0.2188	32	0.0000	18
chr22	16164263	16164263	G	A	0.1905	21	0.0000	18		53	AP000525.9,AP000525.10	intron_variant	AP000525.9:ENST00000447898:intron_variant:MODIFIER:exon2/3:n.203-1776C>T:,AP000525.10:ENST00000440946:intron_variant:MODIFIER:exon1/2:n.324-219G>A:,AP000525.9:ENST00000437781:intron_variant:MODIFIER:exon6/7:n.741-1776C>T:,AP000525.9:ENST00000413768:intron_variant:MODIFIER:exon6/7:n.719-1776C>T:,AP000525.10:ENST00000609679:intron_variant:MODIFIER:exon1/2:n.265-219G>A:,AP000525.9:ENST00000383038:intron_variant:MODIFIER:exon6/7:n.712-1776C>T:						rs2298424	0.0000	0.0000	0.0000																					0		0.1481	27	0.0000	24
chr22	24259754	24259754	T	C	0.1538	27	0.0000	26		53	AP000350.5-AP000350.6	intergenic_region	AP000350.5-AP000350.6:ENSG00000273295-ENSG00000225282:intergenic_region:MODIFIER::n.24259754T>C:							0.0000	0.0000	0.0000																					0		0.1333	30	0.0000	26
chr22	24265045	24265045	T	C	0.1739	24	0.0000	29		54	AP000350.5-AP000350.6	intergenic_region	AP000350.5-AP000350.6:ENSG00000273295-ENSG00000225282:intergenic_region:MODIFIER::n.24265045T>C:							0.0000	0.0000	0.0000																					0		0.2083	24	0.0345	29
chr22	24505987	24505987	A	G	0.2609	23	0.0789	38		51	CABIN1	intron_variant	CABIN1:ENST00000263119:intron_variant:MODIFIER:exon26/36:c.4118-3546A>G:,CABIN1:ENST00000405822:intron_variant:MODIFIER:exon25/35:c.3881-3546A>G:,CABIN1:ENST00000398319:intron_variant:MODIFIER:exon26/36:c.4118-3546A>G:,CABIN1:ENST00000467937:intron_variant:MODIFIER:exon1/2:n.171-3546A>G:			May be required for replication-independent chromatin assembly. May serve as a negative regulator of T-cell receptor (TCR) signaling via inhibition of calcineurin. Inhibition of activated calcineurin is dependent on both PKC and calcium signals	Control of skeletal myogenesis by HDAC & calcium/calmodulin-dependent kinase (CaMK);Role of MEF2D in T-cell Apoptosis			0.0000	0.0000	0.0000																					0		0.2609	23	0.0789	38
chr22	24968608	24968608	A	G	0.1282	40	0.0000	32		66	SNRPD3	3_prime_UTR_variant,intron_variant	SNRPD3:ENST00000215829:3_prime_UTR_variant:MODIFIER:exon4/4:c.*663A>G:,SNRPD3:ENST00000402849:intron_variant:MODIFIER:exon4/4:c.363+579A>G:,SNRPD3:ENST00000404603:intron_variant:MODIFIER:exon4/6:c.*40+623A>G:,SNRPD3:ENST00000439775:intron_variant:MODIFIER:exon4/6:c.*35+579A>G:		Systemic lupus erythematosus	Appears to function in the U7 snRNP complex that is involved in histone 3'-end processing. Binds to the downstream cleavage product (DCP) of histone pre-mRNA in a U7 snRNP dependent manner				0.0000	0.0000	0.0000																					0		0.1500	40	0.0000	32
chr22	30883584	30883584	T	C	0.2000	20	0.0000	18		51	RP4-539M6.14	intron_variant	RP4-539M6.14:ENST00000610156:intron_variant:MODIFIER:exon1/2:n.486+3758T>C:							0.0000	0.0000	0.0000																					0		0.2000	20	0.0000	18
chr22	36548922	36548922	T	C	0.1842	38	0.0238	42		51	APOL3	intron_variant	APOL3:ENST00000349314:intron_variant:MODIFIER:exon1/2:c.224-7275A>G:,APOL3:ENST00000397293:intron_variant:MODIFIER:exon1/3:c.-87-3732A>G:,APOL3:ENST00000424878:intron_variant:MODIFIER:exon2/3:c.-377-7275A>G:,APOL3:ENST00000397289:intron_variant:MODIFIER:exon1/3:c.224-3732A>G:,APOL3:ENST00000422426:intron_variant:MODIFIER:exon1/4:c.224-3503A>G:,APOL3:ENST00000432700:intron_variant:MODIFIER:exon1/3:c.224-3503A>G:,APOL3:ENST00000361710:intron_variant:MODIFIER:exon2/3:c.-377-7275A>G:,APOL3:ENST00000397287:intron_variant:MODIFIER:exon3/4:c.-377-7275A>G:,APOL3:ENST00000487355:intron_variant:MODIFIER:exon2/4:c.*150-3732A>G:,APOL3:ENST00000487423:intron_variant:MODIFIER:exon1/2:n.93+3970A>G:,APOL3:ENST00000426939:intron_variant:MODIFIER:exon1/4:c.86-3732A>G:,APOL3:ENST00000534251:intron_variant:MODIFIER:exon1/3:n.107-3689A>G:,APOL3:ENST00000531195:intron_variant:MODIFIER:exon1/3:c.86-3732A>G:,APOL3:ENST00000487783:intron_variant:MODIFIER:exon2/4:c.*107+411A>G:,APOL3:ENST00000525184:intron_variant:MODIFIER:exon1/2:n.138-3732A>G:,APOL3:ENST00000485453:intron_variant:MODIFIER:exon1/2:n.96-3503A>G:,APOL3:ENST00000530895:intron_variant:MODIFIER:exon1/2:c.86-3503A>G:,APOL3:ENST00000472303:intron_variant:MODIFIER:exon1/3:c.86-2910A>G:			May affect the movement of lipids in the cytoplasm or allow the binding of lipids to organelles				0.0000	0.0000	0.0000																					0		0.1842	38	0.0238	42
chr22	38343683	38343683	A	G	0.2500	16	0.0000	20		51	C22orf23	intron_variant	C22orf23:ENST00000249079:intron_variant:MODIFIER:exon3/6:c.167-213T>C:,C22orf23:ENST00000403305:intron_variant:MODIFIER:exon3/6:c.167-213T>C:,C22orf23:ENST00000403026:intron_variant:MODIFIER:exon3/6:c.167-213T>C:,C22orf23:ENST00000418863:intron_variant:MODIFIER:exon3/5:c.167-213T>C:,C22orf23:ENST00000422191:intron_variant:MODIFIER:exon2/3:c.167-213T>C:							0.0000	0.0000	0.0000																					0		0.2500	16	0.0000	20
chr22	39414772	39414772	A	G	0.2381	21	0.0588	34		52	APOBEC3C,APOBEC3D	3_prime_UTR_variant,intron_variant	APOBEC3C:ENST00000361441:3_prime_UTR_variant:MODIFIER:exon4/4:c.*380A>G:,APOBEC3C:ENST00000428892:3_prime_UTR_variant:MODIFIER:exon3/3:c.*610A>G:,APOBEC3D:ENST00000381568:intron_variant:MODIFIER:exon1/6:c.18-4055A>G:		Atrazine degradation	DNA deaminase (cytidine deaminase) which acts as an inhibitor of retrovirus replication and retrotransposon mobility via deaminase-dependent and -independent mechanisms. After the penetration of retroviral nucleocapsids into target cells of infection and the initiation of reverse transcription, it can induce the conversion of cytosine to uracil in the minus-sense single-strand viral DNA, leading to G-to-A hypermutations in the subsequent plus-strand viral DNA. The resultant detrimental levels of mutations in the proviral genome, along with a deamination- independent mechanism that works prior to the proviral integration, together exert efficient antiretroviral effects in infected target cells. Selectively targets single-stranded DNA and does not deaminate double-stranded DNA or single-or double- stranded RNA. Exhibits antiviral activity against simian immunodeficiency virus (SIV), hepatitis B virus (HBV), herpes simplex virus 1 (HHV-1) and Epstein-Barr virus (EBV) and may inhibit the mobility of LTR and non-LTR retrotransposons. May also play a role in the epigenetic regulation of gene expression through the process of active DNA demethylation.,DNA deaminase (cytidine deaminase) which acts as an inhibitor of retrovirus replication and retrotransposon mobility via deaminase-dependent and -independent mechanisms. Exhibits antiviral activity against vif-deficient HIV-1. After the penetration of retroviral nucleocapsids into target cells of infection and the initiation of reverse transcription, it can induce the conversion of cytosine to uracil in the minus-sense single-strand viral DNA, leading to G-to-A hypermutations in the subsequent plus-strand viral DNA. The resultant detrimental levels of mutations in the proviral genome, along with a deamination- independent mechanism that works prior to the proviral integration, together exert efficient antiretroviral effects in infected target cells. Selectively targets single-stranded DNA and does not deaminate double-stranded DNA or single-or double- stranded RNA. May inhibit the mobility of LTR and non-LTR retrotransposons				0.0000	0.0000	0.0000																					0		0.2381	21	0.0588	34
chr22	43385034	43385034	T	C	0.1379	29	0.0000	18		53	PACSIN2	intron_variant	PACSIN2:ENST00000263246:intron_variant:MODIFIER:exon1/10:c.-78+25993A>G:,PACSIN2:ENST00000337959:intron_variant:MODIFIER:exon1/9:c.-78+25993A>G:,PACSIN2:ENST00000453643:intron_variant:MODIFIER:exon2/4:c.-78+4592A>G:,PACSIN2:ENST00000422336:intron_variant:MODIFIER:exon1/3:c.-78+13282A>G:,PACSIN2:ENST00000445706:intron_variant:MODIFIER:exon1/3:c.-78+25993A>G:			Plays a role in the formation of normal, flask-shaped caveolae at the cell membrane. Recruits DNM2 to caveolae, and thereby plays a role in caveola-mediated endocytosis. Plays a role in intracellular vesicle-mediated transport. Binds to membranes via its F-BAR domain and promotes membrane tubulation. Plays a role in the internalization of cell-surface receptors. Is not required for internalization of EGFR after EGF stimulus, but contributes to the internalization of EGFR in the absence of EGF stimulus				0.0000	0.0000	0.0000																					0		0.1379	29	0.0000	18
chr22	43408075	43408075	T	C	0.2105	19	0.0000	22		56	PACSIN2	intron_variant	PACSIN2:ENST00000263246:intron_variant:MODIFIER:exon1/10:c.-78+2952A>G:,PACSIN2:ENST00000337959:intron_variant:MODIFIER:exon1/9:c.-78+2952A>G:,PACSIN2:ENST00000453643:intron_variant:MODIFIER:exon1/4:c.-239+2952A>G:,PACSIN2:ENST00000445706:intron_variant:MODIFIER:exon1/3:c.-78+2952A>G:			Plays a role in the formation of normal, flask-shaped caveolae at the cell membrane. Recruits DNM2 to caveolae, and thereby plays a role in caveola-mediated endocytosis. Plays a role in intracellular vesicle-mediated transport. Binds to membranes via its F-BAR domain and promotes membrane tubulation. Plays a role in the internalization of cell-surface receptors. Is not required for internalization of EGFR after EGF stimulus, but contributes to the internalization of EGFR in the absence of EGF stimulus				0.0000	0.0000	0.0000																					0		0.2105	19	0.0000	22
chr22	45736849	45736849	A	G	0.1613	32	0.0000	21		63	FAM118A	3_prime_UTR_variant	FAM118A:ENST00000216214:3_prime_UTR_variant:MODIFIER:exon10/10:c.*563A>G:							0.0000	0.0000	0.0000																					0		0.1562	32	0.0000	21
